Suzanne Arnold

Oct 30, 2024 | jamanetwork.com | Suzanne Arnold |John A. Spertus |Kensey L. Gosch |Shannon M. Dunlay

Severe tricuspid regurgitation is a common finding in patients with a variety of comorbid conditions, including chronic heart failure, lung disease, pulmonary hypertension, atrial fibrillation, and right ventricular dysfunction and is associated with impaired health status and worse survival.1 Isolated tricuspid valve surgery is associated with relatively high morbidity and/or mortality, often in the setting of concomitant severe right ventricular dysfunction, pulmonary hypertension, and...

Oct 30, 2024 | jamanetwork.com | Suzanne Arnold |Kansas City |John A. Spertus |Shannon M. Dunlay

Key PointsQuestion  Is the Kansas City Cardiomyopathy Questionnaire (KCCQ) a valid disease-specific health status measure in patients with severe tricuspid regurgitation (TR)? Findings  In this cohort study, data on 2693 patients from 11 clinical trials of various transcatheter tricuspid valve interventions (TTVI) from 2 device manufacturers were pooled and then analyzed by an academic analytic center.

Oct 16, 2024 | jamanetwork.com | Suzanne Arnold |Wayne Batchelor |Inova Heart |Marcus Heart

Trends in Transcatheter Aortic Valve Replacement Outcomes: Insights From the STS/ACC TVT Registry Key PointsQuestion  Why have mortality rates after transcatheter aortic valve replacement (TAVR) plateaued since 2019, despite modest declines in patient-level risk and procedural improvements over the same time period?

Oct 6, 2024 | jacc.org | Suzanne Arnold |Rebecca T. Hahn |Vinod Thourani |Raj R. Makkar

Introduction Severe tricuspid regurgitation (TR) can result in a substantial burden of symptoms, such as dyspnea, fatigue, and edema, which can negatively impact patients’ physical and social function and their quality of life.1-4 Although it was expected that treatment of severe TR would lead to reductions in both mortality and heart failure hospitalization, to date, the only proven benefit of transcatheter tricuspid valve intervention is improved health status.5-7 In both the TRILUMINATE...

Mar 14, 2024 | jacc.org | Hani Jneid |Joanna Chikwe |Suzanne Arnold |Robert O. Bonow

Biykem Bozkurt, MD, PhD, FACC, FAHA, ChairBoback Ziaeian, MD, PhD, FACC, FAHA, Chair-ElectZaid Almarzooq, MB BCh, FACC#H. Vernon (Skip) Anderson, MD, FACC, FAHA, FSCAIIngabire Grace Balinda, MD, MS, FACCAnkeet Bhatt, MD, MBA#Jeffrey Bruckel, MD, MPH, FACCLeslie Cho, MD, FACC, FSCAISandeep Das, MD, MPH, FACC, FAHA#Michael Dorsch, PharmD, MS, FACC, FAHADaniel Duprez, MD, PhD, FACC, FAHAJoao F. Monteiro Ferreira, MD, PhD, FACC#Marat Fudim, MD, MHS#Stacy Garcia, MBA-HCM, BSN, RN, RT(R)Paul L.